Fragment-based screening, what can we learn from published hits? This talk was given by Dr Chris Swain, Cambridge MedCem Consulting, at Optibrium’s Drug Discovery Consultants’ Day – November 2013. A copy of Chris’ slides can be downloaded here....
Drug Optimisation article co-authored with Nigel Greene and Falgun Shah compound safety prediction group. In the article, we discuss new ‘rule induction’ methods that explore complex data to find interpretable, multi-parameter rules, tailored to any drug...
Preprint: Addressing Toxicity Risk when Designing and Selecting Compounds in Early Drug Discovery We’ve just submitted this article, co-authored with Chris Barber, CSO of Lhasa Limited. In it, we discuss how application of expert knowledge-based predictions of...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.